Actuation system and method for an implantable infusion pump

• US 7,559,926 B1
• Filed: 01/13/2004
• Issued: 07/14/2009
• Est. Priority Date: 01/13/2003
• Status: Expired due to Fees

• Current Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Advanced Neuromodulation Systems Incorporated (Abbott Laboratories Incorporated)
• Inventors: Blischak, Brian
• Primary Examiner(s): Lucchesi; Nicholas D
• Assistant Examiner(s): BERDICHEVSKY, AARTI
• Application Number:
  US10/755,985
• Time in Patent Office: 2,009 Days
• Field of Search: 604/503, 604/502, 604/71, 604/131, 604/82, 604132-133, 604/140, 604/142, 60428801-28804, 604/890.1, 604/891.1
• US Class Current: 604/891.1
• CPC Class Codes: A61M 2005/1405 Patient controlled analgesia [PCA]
• CPC Class Codes: A61M 5/14276 specially adapted for implantation
• CPC Class Codes: A61M 5/1428 with manual pumping action
• CPC Class Codes: A61M 5/14526 the piston being actuated by fluid pressure

Abstract

The invention relates to an actuation system and method for an implantable infusion pump. In an example, a working fluid is placed in an actuator. Upon actuation, the working fluid is driven into a piston cylinder. Upon deactuation, the actuator draws the fluid from the cylinder through a restrictor at a rate dictated by the motivating force, fluid viscosity, and restriction. Driving of the piston may produce a bolus dosage or fill a supplemental flow chamber for subsequent delivery. The exemplary system may be configured by selecting a fluid volume and a viscosity. These, in combination, produce a prescribed fluid delivery rate (or recharge rate) and cumulative flow volume provided to a patient over a time period or in a bolus dose. The system may also be configured to limit the total dosage of a bolus injection, or the rate of a supplemental dosage. In this manner, the system is safe, preventing overdose.

Claims

1. A method of operating an implantable infusion drug pump, comprising:

storing infusate in a main reservoir of the implantable infusion drug pump, wherein a substantially constant fluid pressure is provided to the infusate in the main reservoir;

driving infusate from the main reservoir through a flow restrictor and out through a discharge port of the implantable infusion drug pump at a substantially constant basal infusion rate;

providing a temporary bolus infusion rate in response to patient manipulation of provided simultaneously to the basal infusion rate, wherein the providing a temporary bolus infusion rate comprises;

(i) driving fluid into a working fluid reservoir by pressure applied by the actuator, the working fluid reservoir and a secondary reservoir being mechanically coupled, the driving of fluid into the working fluid reservoir causing infusate to be drawn from the main reservoir into the secondary reservoir;

(ii) providing pressure on infusate in the secondary reservoir to drive the infusate from the secondary reservoir, driving of infusate from the secondary reservoir occurring simultaneously with fluid being driven from the working fluid reservoir toward the actuator; and

(iii) controlling a discharge rate from the secondary reservoir to the discharge port using a flow restrictor;

wherein the implantable infusion drug pump does not comprise an electrical motor or an electrical power supply;

wherein the implantable infusion drug pump comprises at least one one-way valve that enables the secondary reservoir to be filled without being subjected to a flow rate limitation of a flow restrictor of the implantable drug infusion pump.

2. The method of claim 1 wherein the secondary and working fluid reservoirs are defined by respective piston cylinders.

4. The method of claim 1 wherein the driving infusate from the main reservoir is performed by an elastomeric diaphragm.

3. The method of 1 wherein the secondary reservoir is adapted to hold a maximum fluid volume that is greater than a maximum fluid volume of the working fluid reservoir.